55 related articles for article (PubMed ID: 8609715)
21. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
22. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia.
Xie XY; Robb D; Chow S; Hedley DW
Leukemia; 1995 Nov; 9(11):1882-7. PubMed ID: 7475279
[TBL] [Abstract][Full Text] [Related]
23. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
26. Relationship between MDR1 gene and surface markers in acute myeloid leukemia.
Zöchbauer S; Schwarzinger I; Strobl H; Lechner K; Pirker R
Anticancer Res; 1997; 17(1B):749-52. PubMed ID: 9066614
[TBL] [Abstract][Full Text] [Related]
27. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
[TBL] [Abstract][Full Text] [Related]
28. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
[TBL] [Abstract][Full Text] [Related]
29. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
31. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
32. MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.
van den Heuvel-Eibrink MM; van der Holt B; te Boekhorst PA; Pieters R; Schoester M; Löwenberg B; Sonneveld P
Br J Haematol; 1997 Oct; 99(1):76-83. PubMed ID: 9359506
[TBL] [Abstract][Full Text] [Related]
33. Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the Childrens Cancer Group.
Smith FO; Broudy VC; Zsebo KM; Lampkin BC; Buckley CV; Buckley JD; Opie T; Woods WG; Hammond GD; Bernstein ID
Blood; 1994 Aug; 84(3):847-52. PubMed ID: 7519080
[TBL] [Abstract][Full Text] [Related]
34. [P-glycoprotein expression in radiation-associated acute myeloid leukemia].
Bebeshko VH; Bazyka DA; Klymenko SV; Maznichenko OL; Holiarnik NA; Liaskovs'ka OV; Il'ienko IM; Tretiak NM; Vdovtsov OO; Serbinenko TM; Zubryts'ka TB; Zinchenko VN
Lik Sprava; 2005; (3):29-32. PubMed ID: 16025673
[TBL] [Abstract][Full Text] [Related]
35. Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors.
Schwab R; Micsik T; Szokolóczi O; Schafer E; Tihanyi B; Tihanyi T; Kupcsulik P; Diófalvi K; Mersich T; Besznyak I; Zarand A; Mihalik R; Sarkadi B; Kéri G; Pap A; Jakab F; Kopper L; Petak I
Assay Drug Dev Technol; 2007 Aug; 5(4):541-50. PubMed ID: 17767422
[TBL] [Abstract][Full Text] [Related]
36. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia.
Karászi E; Jakab K; Homolya L; Szakács G; Holló Z; Telek B; Kiss A; Rejtô L; Nahajevszky S; Sarkadi B; Kappelmayer J
Br J Haematol; 2001 Feb; 112(2):308-14. PubMed ID: 11167823
[TBL] [Abstract][Full Text] [Related]
37. High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis.
Steiner K; Graf M; Hecht K; Reif S; Rossbacher L; Pfister K; Kolb HJ; Schmetzer HM; Multhoff G
Leukemia; 2006 Nov; 20(11):2076-9. PubMed ID: 16990768
[No Abstract] [Full Text] [Related]
38. High reactivity of monoclonal antibody (TO73) with human malignant tumor cell line.
Kakihara T; Fukuda T; Yamada T; Tanaka A; Uchiyama M; Naito M; Emura I
Pathol Int; 1997 Sep; 47(9):608-13. PubMed ID: 9311011
[TBL] [Abstract][Full Text] [Related]
39. Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies.
Megías-Vericat JE; Rojas L; Herrero MJ; Bosó V; Montesinos P; Moscardó F; Poveda JL; Sanz MÁ; Aliño SF
Pharmacogenomics J; 2015 Apr; 15(2):109-18. PubMed ID: 25558979
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial.
Pallis M; Hills R; White P; Grundy M; Russell N; Burnett A
Blood Cancer J; 2011 Jun; 1(6):e23. PubMed ID: 22829167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
